Venture Certified
| 혁신성장유형 | 2022-06-02 ~ 2025-06-01 | 20220602030088 | 2022-06-02 |
| 혁신성장유형 | 2025-06-02 ~ 2028-06-01 | 20250730030037 | 2022-06-02 |
Revenue CAGR -3.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 154.6B | 180.2B | 167.0B |
| Operating Profit | 5.6B | 16.2B | 15.8B |
| Net Profit | 2.6B | 13.6B | 12.0B |
| Total Assets | 170.6B | 164.2B | 146.7B |
| Total Liabilities | 127.0B | 121.9B | 117.5B |
| Total Equity | 43.6B | 42.3B | 29.1B |
▼ 11.0%
▼ 65.2%
▼ 60.9%
▼ 15.7%
▼ 84.0%
| Name | Position | Role |
|---|---|---|
| 박민봉 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "박민봉",
"certificate": [
{
"cert_number": "20220602030088",
"changes": "",
"disclosure_date": "2022-06-02",
"first_cert_date": "2022-06-02",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2022-06-02 ~ 2025-06-01"
},
{
"cert_number": "20250730030037",
"changes": "",
"disclosure_date": "2025-07-30",
"first_cert_date": "2022-06-02",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2025-06-02 ~ 2028-06-01"
}
],
"company_name": "(주) 필코리아테크놀로지",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 528290000,
"cost_of_sales": 11674952000,
"current_assets": 7226707000,
"current_liabilities": 6801578000,
"gross_profit": 5026616000,
"net_income": 1204219000,
"net_income_bs": 1180744000,
"non_current_assets": 7440650000,
"non_current_liabilities": 4953263000,
"non_operating_expenses": 596425000,
"non_operating_income": 220616000,
"operating_profit": 1580028000,
"revenue": 16701567000,
"sga_expenses": 3446588000,
"total_assets": 14667357000,
"total_equity": 2912516000,
"total_liabilities": 11754841000
},
"2023": {
"capital_stock": 528290000,
"cost_of_sales": 13019032000,
"current_assets": 9299558000,
"current_liabilities": 8892772000,
"gross_profit": 5005419000,
"net_income": 1357748000,
"net_income_bs": 1316513000,
"non_current_assets": 7117102000,
"non_current_liabilities": 3294860000,
"non_operating_expenses": 533942000,
"non_operating_income": 269289000,
"operating_profit": 1622401000,
"revenue": 18024451000,
"sga_expenses": 3383018000,
"total_assets": 16416661000,
"total_equity": 4229029000,
"total_liabilities": 12187632000
},
"2024": {
"capital_stock": 528290000,
"cost_of_sales": 11981041000,
"current_assets": 10130345000,
"current_liabilities": 10414049000,
"gross_profit": 3478086000,
"net_income": 256677000,
"net_income_bs": 127558000,
"non_current_assets": 6927955000,
"non_current_liabilities": 2287664000,
"non_operating_expenses": 512798000,
"non_operating_income": 212179000,
"operating_profit": 557296000,
"revenue": 15459128000,
"sga_expenses": 2920790000,
"total_assets": 17058300000,
"total_equity": 4356587000,
"total_liabilities": 12701713000
}
},
"industry": "물리, 화학 및 생물학 연구개발업",
"investment": [],
"main_products": "과학기자재 및 시약",
"phone": "02-2105-****",
"years": [
2024,
2023,
2022
]
}